Check Nls Pharmaceutics Ag market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.0M
EPS (TTM)
0Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-3.6M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
6704100.00%
Compare market cap, revenue, PE, and other key metrics of Nls Pharmaceutics Ag with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$9.0M | NA | NA | 0.00% | ||
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Nls Pharmaceutics Ag stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Nls Pharmaceutics Ag investment value today
Current value as on today
₹41,151
Returns
Returns from Nls Pharmaceutics Ag Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Nls Pharmaceutics Ag. Average target price of $6
Get share price movements and forecasts by analysts on Nls Pharmaceutics Ag.
What analysts predicted
67%UPSIDE
Target Price
$6
Current Price
$1.98
Analyzed by
6 Analysts
Target
$6.00
Nls Pharmaceutics Ag target price $6, a slight upside of 67% compared to current price of $1.98. According to 6 analysts rating.
Search interest for Nls Pharmaceutics Ag Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 205.9%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 131.3%
Price Dip
In the last 1 month, NLSP stock has moved down by -21.3%
Organisation | Nls Pharmaceutics Ag |
Headquarters | The Circle 6, Zurich, Switzerland, 8058 |
Industry | Health Technology |
CEO | Mr. Alexander Zwyer M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Alexander Zwyer M.B.A. | Co-Founder, CEO & Director |
Dr. Eric Konofal M.D., Ph.D. | Co-Founder & Chief Scientific Officer |
Ms. Nicole Fernandez-McGovern CPA | Chief Financial Officer |
Nls Pharmaceutics Ag share price today is $1.98 as on . Nls Pharmaceutics Ag share today touched a day high of $2 and a low of $1.83.
Nls Pharmaceutics Ag share touched a 52 week high of $6.97 on and a 52 week low of $1.3 on . Nls Pharmaceutics Ag stock price today i.e. is trending at $1.98,which is 71.60% down from its 52 week high and 52.31% up from its 52 week low.
Nls Pharmaceutics Ag market capitalisation is $0.00T as on .
Indian investors can start investing in Nls Pharmaceutics Ag (NLSP) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Nls Pharmaceutics Ag stock (as per the Rupee-Dollar exchange rate as on ).
Based on Nls Pharmaceutics Ag share’s latest price of $1.98 as on September 18, 2025 at 8:39 pm IST, you will get 5.0505 shares of Nls Pharmaceutics Ag. Learn more about
fractional shares .